D
Diana Hernández-Flórez
Researcher at Hospital General Universitario Gregorio Marañón
Publications - 29
Citations - 252
Diana Hernández-Flórez is an academic researcher from Hospital General Universitario Gregorio Marañón. The author has contributed to research in topics: Rheumatoid arthritis & Synovitis. The author has an hindex of 7, co-authored 28 publications receiving 218 citations.
Papers
More filters
Journal ArticleDOI
Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis
Esperanza Naredo,Lara Valor,Inmaculada de la Torre,María Montoro,N. Bello,Julia Martínez-Barrio,Lina Martínez-Estupiñán,Juan Carlos Nieto,J.G. Ovalles-Bonilla,Diana Hernández-Flórez,Carlos M. González,Francisco Javier López-Longo,Indalecio Monteagudo,Luis Carreño +13 more
TL;DR: The results suggest that the presence of Doppler-detected synovitis may predict BT tapering failure in RA patients in sustained clinical remission.
Journal ArticleDOI
Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment
Iustina Janta,Lina Martínez-Estupiñán,Lara Valor,María Montoro,Ofelia Baniandrés Rodríguez,Ignacio Hernández Aragüés,N. Bello,Diana Hernández-Flórez,M. Hinojosa,Julia Martínez-Barrio,Juan Carlos Nieto-González,J.G. Ovalles-Bonilla,Carlos M. González,Francisco Javier López-Longo,Indalecio Monteagudo,Esperanza Naredo,Luis Carreño +16 more
TL;DR: Clinical assessment, MSUS variables, and MDA status are similar in patients receiving full and tapered dosage of bDMARDs and between patients with and without concomitant sDMARD.
Journal Article
Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.
José Rosas,Francisca Llinares-Tello,Inmaculada de la Torre,C. Santos-Ramírez,José Miguel Senabre-Gallego,Lara Valor,Xavier Barber-Vallés,Diana Hernández-Flórez,G. Santos-Soler,Esteban Salas-Heredia,Luis Carreño +10 more
TL;DR: The presence of anti-ADL antibodies was associated with a loss of clinical efficacy of ADL and should be maintained >4.3 mg/L, in patients with ADL levels >11.3mg/L.
Journal Article
The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?
Rosario Morales-Lozano,Julia Martínez-Barrio,María Luz González-Fernández,Francisco Javier López-Longo,J.G. Ovalles-Bonilla,Lara Valor,Iustina Janta,Juan Carlos Nieto,Diana Hernández-Flórez,Carlos M. González,Indalecio Monteagudo,Jesús Garrido,Luis Carreño,Esperanza Naredo +13 more
TL;DR: SLE patients showed more biomechanical and US abnormalities in the feet than controls, which were not captured by standardised assessment of the disease activity, and the relationship between these abnormalities and SLE activity was assessed.
Journal ArticleDOI
Anti-TNF treatments in rheumatoid arthritis: economic impact of dosage modification
de la Torre I,Lara Valor,Juan Carlos Nieto,Diana Hernández-Flórez,L P Martínez,Carlos M. González,Indalecio Monteagudo,Longo Jl,María Montoro,Luis Carreño +9 more
TL;DR: The authors analyzed the costs of the medication in order to estimate the mean patient-year cost, the annual costs related to clinical efficacy and the cost per responder patient to anti-TNF treatment when dosage modification is undertaken in daily clinical practice.